Observational study on cardiac biomarkers in patients with cardiomyopathy in underlying muscular dystrophy disease.

Observational study on cardiac biomarkers in patients with cardiomyopathy in underlying muscular dystrophy disease. - KYMA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028058

Enrollment

Registered

2023-03-07

Start date

2023-03-13

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I42 G71.0

Interventions

Group 1: No intervention planned. Patients will be invited to our cardiomyopathy outpatients’ clinic and trial blood samples will be withdrawn. Serial blood sampling at 0 hour and 1 hour and after 6 m

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: - Written informed consent - Diagnosed dystrophic myopathy - Age >18 years

Exclusion criteria

Exclusion criteria: - Patients with poor veins - Chronic hemodialysis - No consent

Design outcomes

Primary

Measure	Time frame
Primary goals: - Prevalence of stable troponin cinetics defined as troponin T high sensitive (hour 0) : troponin T high sensitive (hour 1) < 5 ng/l Secondary: - Calculation of the reference change value (RCV) within 6 months follow-up (5)	—

Secondary

Measure	Time frame
Implementing a longitudinal register in order to examine the prognostic value of new biomarkers	—

Countries

Germany

Contacts

Public ContactMustafa Yildirim

Universitätsklinikum Heidelberg/Innere III - Abteilung für Kardiologie, Angiologie und Pneumologie

Mustafa.yildirim@med.uni-heidelberg.de+49 6221 56 - 310918

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026